-Salinas, R. G., Magri, S., & Ruta, A. Certolizumab pegol in severe rheumatoid arthritis. Real-life evidence in an Argentine cohort: Goal achievement (t2t) at 3 months and predictive factors. Panamerican League of Associations of Rheumatology (PANLAR).
Chicago Style (17th ed.) Citation-Salinas, Rodrigo Garcia, Sebastian Magri, and Alvaro Ruta. Certolizumab Pegol in Severe Rheumatoid Arthritis. Real-life Evidence in an Argentine Cohort: Goal Achievement (t2t) at 3 Months and Predictive Factors. Panamerican League of Associations of Rheumatology (PANLAR).
MLA (9th ed.) Citation-Salinas, Rodrigo Garcia, et al. Certolizumab Pegol in Severe Rheumatoid Arthritis. Real-life Evidence in an Argentine Cohort: Goal Achievement (t2t) at 3 Months and Predictive Factors. Panamerican League of Associations of Rheumatology (PANLAR).